Gubra 過去の業績
過去 基準チェック /06
Gubra's earnings have been declining at an average annual rate of -92.7%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 10% per year.
主要情報
-92.7%
収益成長率
-124.4%
EPS成長率
| Life Sciences 業界の成長 | 26.8% |
| 収益成長率 | 10.0% |
| 株主資本利益率 | -10.0% |
| ネット・マージン | -20.8% |
| 次回の業績アップデート | 28 Feb 2025 |
最近の業績更新
Recent updates
収支内訳
Gubra の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 224 | -47 | 86 | 97 |
| 31 Mar 24 | 214 | -46 | 80 | 93 |
| 31 Dec 23 | 205 | -45 | 75 | 89 |
| 30 Sep 23 | 204 | -26 | 73 | 83 |
| 30 Jun 23 | 204 | -7 | 71 | 77 |
| 31 Mar 23 | 201 | -1 | 69 | 67 |
| 31 Dec 22 | 199 | 4 | 67 | 57 |
| 31 Dec 21 | 255 | 68 | 52 | 27 |
| 31 Dec 20 | 172 | 13 | 45 | 34 |
質の高い収益: PI3 is currently unprofitable.
利益率の向上: PI3 is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: PI3 is unprofitable, and losses have increased over the past 5 years at a rate of 92.7% per year.
成長の加速: Unable to compare PI3's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: PI3 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).
株主資本利益率
高いROE: PI3 has a negative Return on Equity (-10.03%), as it is currently unprofitable.